BR0112140B1 - comprimido de liberaÇço controlada, processo para a fabricaÇço, em um meio aquoso, de um excipiente de liberaÇço controlada e amido reticulado de elevado teor de amilose. - Google Patents

comprimido de liberaÇço controlada, processo para a fabricaÇço, em um meio aquoso, de um excipiente de liberaÇço controlada e amido reticulado de elevado teor de amilose.

Info

Publication number
BR0112140B1
BR0112140B1 BRPI0112140-5A BR0112140A BR0112140B1 BR 0112140 B1 BR0112140 B1 BR 0112140B1 BR 0112140 A BR0112140 A BR 0112140A BR 0112140 B1 BR0112140 B1 BR 0112140B1
Authority
BR
Brazil
Prior art keywords
controlled release
manufacture
aqueous medium
high amylose
linked starch
Prior art date
Application number
BRPI0112140-5A
Other languages
English (en)
Other versions
BRPI0112140B8 (pt
BR0112140A (pt
Inventor
Vincent Lenaerts
Bogaret Elsie Van
Cyril Desevaux
Reiner Hopcke
Francois Chouinard
Roland Herwig Friedrich Beck
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24427807&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0112140(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of BR0112140A publication Critical patent/BR0112140A/pt
Publication of BR0112140B1 publication Critical patent/BR0112140B1/pt
Publication of BRPI0112140B8 publication Critical patent/BRPI0112140B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B33/00—Preparation of derivatives of amylose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0112140A 2000-06-29 2001-06-26 comprimido de liberação controlada, processo para a fabricação, em um meio aquoso, de um excipiente de liberação controlada e amido reticulado de elevado teor de amilose. BRPI0112140B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/606,399 US6607748B1 (en) 2000-06-29 2000-06-29 Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
PCT/US2001/020319 WO2002002084A1 (en) 2000-06-29 2001-06-26 Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture

Publications (3)

Publication Number Publication Date
BR0112140A BR0112140A (pt) 2003-10-07
BR0112140B1 true BR0112140B1 (pt) 2013-04-30
BRPI0112140B8 BRPI0112140B8 (pt) 2021-05-25

Family

ID=24427807

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0112140A BRPI0112140B8 (pt) 2000-06-29 2001-06-26 comprimido de liberação controlada, processo para a fabricação, em um meio aquoso, de um excipiente de liberação controlada e amido reticulado de elevado teor de amilose.

Country Status (27)

Country Link
US (2) US6607748B1 (pt)
EP (1) EP1305009B1 (pt)
JP (1) JP5025066B2 (pt)
KR (1) KR100840393B1 (pt)
CN (1) CN100352509C (pt)
AR (1) AR029549A1 (pt)
AT (1) ATE328585T1 (pt)
AU (2) AU2001271481B2 (pt)
BR (1) BRPI0112140B8 (pt)
CA (1) CA2414349C (pt)
CZ (1) CZ300152B6 (pt)
DE (1) DE60120413T2 (pt)
DK (1) DK1305009T3 (pt)
ES (1) ES2272499T3 (pt)
HK (1) HK1059574A1 (pt)
HU (1) HUP0301302A2 (pt)
IL (2) IL153654A0 (pt)
MX (1) MXPA03000035A (pt)
MY (1) MY128308A (pt)
NO (1) NO20026254L (pt)
NZ (1) NZ523644A (pt)
PL (1) PL202177B1 (pt)
PT (1) PT1305009E (pt)
RU (1) RU2274443C2 (pt)
SI (1) SI1305009T1 (pt)
TW (1) TWI289460B (pt)
WO (1) WO2002002084A1 (pt)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
NZ514896A (en) * 1998-10-30 2003-11-28 Rj Innovation A method of preventing parturient hypocalcemia in animals and compositions used therein
US6607748B1 (en) * 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
FR2822471B1 (fr) * 2001-03-26 2003-06-13 Roquette Freres Procede de cuisson/sechage d'amidons riches en amylose
WO2003037301A2 (en) * 2001-10-29 2003-05-08 King Pharmaceuticals Research And Development, Inc Oral dosage forms for improving the bioavailability of therapeutic agents
US7815936B2 (en) * 2001-10-30 2010-10-19 Evonik Degussa Gmbh Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
US6949256B2 (en) * 2002-01-18 2005-09-27 Banner Pharmacaps, Inc. Non-gelatin capsule shell formulation
US7887838B2 (en) * 2002-01-18 2011-02-15 Banner Pharmacaps, Inc. Non-gelatin film and method and apparatus for producing same
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
KR20050009983A (ko) * 2002-03-22 2005-01-26 시락 아게 트라마돌의 서방성 제제
US20030191029A1 (en) * 2002-03-28 2003-10-09 Elementis Specialties, Inc. Aqueous-based oil well drilling fluids containing high amylose starch polymers
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
MY142195A (en) * 2002-10-25 2010-10-15 Labopharm Inc Controlled-release compositions
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
RU2328275C2 (ru) * 2002-10-25 2008-07-10 Лабофарм Инк. Композиции трамадола пролонгированного высвобождения с 24-часовым действием
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
CA2503361C (en) * 2002-10-25 2012-02-28 Labopharm Inc. Controlled-release compositions
US6846497B2 (en) * 2003-01-30 2005-01-25 National Starch And Chemical Investment Holding Corporation Rapidly expanding starches with altered crystalline structure
CA2522293A1 (en) * 2003-04-14 2004-10-28 Fmc Corporation Homogeneous, thermoreversible low viscosity polymannan gum films and soft capsules made therefrom
US7816341B2 (en) * 2003-04-14 2010-10-19 Fmc Corporation Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom
US20050008677A1 (en) * 2003-04-14 2005-01-13 Fmc Corporation Delivery system of homogeneous, thermoreversible gel film containing kappa-2 carrageenan
US20050048185A1 (en) * 2003-04-14 2005-03-03 Fmc Corporation Delivery systems of homogeneous, thermoreversible low viscosity polymannan gum films
US20050019295A1 (en) * 2003-04-14 2005-01-27 Fmc Corporation Homogeneous, thermoreversible low viscosity polymannan gum films and soft capsules made therefrom
US20050019294A1 (en) * 2003-04-14 2005-01-27 Fmc Corporation Homogeneous, thermoreversible alginate films and soft capsules made therefrom
US20050013847A1 (en) * 2003-04-14 2005-01-20 Fmc Corporation Delivery systems of homogeneous, thermoreversible alginate films
EP1479381A1 (en) * 2003-05-19 2004-11-24 Euro-Celtique S.A. Pharmaceutical dosage form comprising a solid solution
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
WO2005101979A2 (en) * 2004-04-22 2005-11-03 Mor Research Applications Ltd. Method of food intake management
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20060188631A1 (en) * 2005-02-18 2006-08-24 Kyungsoo Woo Pregelatinized chemically modified resistant starch products and uses thereof
CA2616204C (en) * 2005-09-09 2015-12-01 Labopharm Inc. Sustained drug release composition
US20070190141A1 (en) * 2006-02-16 2007-08-16 Aaron Dely Extended release opiate composition
CN100437113C (zh) * 2006-04-11 2008-11-26 汪运山 一种检测血液中非那西丁与醋氨酚浓度比值的试剂盒
WO2009018169A1 (en) * 2007-07-27 2009-02-05 Auspex Pharmaceuticals, Inc. Substituted cyclohexanols
RU2445320C2 (ru) * 2007-08-31 2012-03-20 Сирал Бельгия Нв Способ получения набухающего в холодной воде сшитого фосфатом желатинизированного крахмала
MX336494B (es) * 2007-10-16 2016-01-21 Paladin Labs Inc Composicion de bicapas para la liberacion controlada de acetaminofeno y tramadol.
GB0722484D0 (en) * 2007-11-15 2007-12-27 Ucl Business Plc Solid compositions
CA2707980C (en) * 2007-12-17 2015-05-12 Labopharm Inc. Misuse preventative, controlled release formulation
UA98684C2 (uk) * 2007-12-28 2012-06-11 Ацьенде Кимике Риуните Анджелини Франческо А.Чи.Р.А.Ф. С.П.А. Композиція повільного вивільнення на основі асоціації глікогену та альгінату
TWI454288B (zh) 2008-01-25 2014-10-01 Gruenenthal Chemie 藥物劑型
KR20100129740A (ko) * 2008-02-19 2010-12-09 맥네일-피피씨, 인코포레이티드 아밀로스 함량이 높은 전분을 포함하는 침지 코팅 조성물
EP2273983B1 (en) 2008-05-09 2016-07-20 Grünenthal GmbH Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
US20100003322A1 (en) * 2008-07-03 2010-01-07 Lai Felix S Enteric coated hydrophobic matrix formulation
US20100068268A1 (en) * 2008-09-15 2010-03-18 Miloud Rahmouni Starch-based microparticles for the release of agents disposed therein
ES2425762T3 (es) * 2008-10-27 2013-10-17 Roquette Freres Polímero insoluble en agua: revestimientos de película a base de derivados de almidón modificado para la liberación dirigida al colon
JP5667575B2 (ja) * 2008-12-16 2015-02-12 パラディン ラブス インコーポレーテッド 誤用を防止する放出制御製剤
BRPI1006902A2 (pt) 2009-01-23 2016-02-16 Aziende Chimiche Riunte Angelini Francesco A C R A F S P A formulação farmacêutica ou alimentícia de liberação controlada, processo para a produção de uma forma farmacêutica ou alimentícia, sistema de liberação controlada, e, uso de um sistema de liberação controlada
ES2560210T3 (es) 2009-07-22 2016-02-17 Grünenthal GmbH Forma de dosificación resistente a la manipulación para opiádes sensibles a la oxidación
CN102573805A (zh) 2009-07-22 2012-07-11 格吕伦塔尔有限公司 热熔挤出的控制释放剂型
ES2569925T3 (es) 2009-09-30 2016-05-13 Acura Pharmaceuticals, Inc. Métodos y composiciones de disuasión del abuso
WO2011095314A2 (en) 2010-02-03 2011-08-11 Grünenthal GmbH Preparation of a powdery pharmaceutical composition by means of an extruder
JP2013518580A (ja) 2010-02-07 2013-05-23 クリアファーマ インダストリーズ リミテッド ヒヨコマメの調製およびその使用
EP2386297A1 (en) * 2010-04-28 2011-11-16 Roquette Frères Indigestible polymer: starch acetate -based film coatings for colon targeting
CA2801620A1 (en) 2010-07-06 2012-01-12 Gruenenthal Gmbh Novel gastro-retentive dosage forms comprising a gaba analog and an opioid
ES2486791T3 (es) 2010-09-02 2014-08-19 Grünenthal GmbH Forma de dosificación resistente a la manipulación que comprende una sal inorgánica
TWI516286B (zh) 2010-09-02 2016-01-11 歌林達股份有限公司 含陰離子聚合物之抗破碎劑型
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
CA2839126A1 (en) 2011-07-29 2013-02-07 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
DK2736495T3 (da) 2011-07-29 2017-11-13 Gruenenthal Gmbh Misbrugsbestandig tablet som tilvejebringer øjeblikkelig frigivelse af lægemiddel
US9511147B2 (en) * 2011-08-12 2016-12-06 Rutgers, The State University Of New Jersey Interpolymer network delivery system
WO2013127831A1 (en) 2012-02-28 2013-09-06 Grünenthal GmbH Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
JP6282261B2 (ja) 2012-04-18 2018-02-21 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 不正使用防止および過量放出防止医薬剤形
GB201207907D0 (en) 2012-05-04 2012-06-20 E Therapeutics Plc Treatment of depression
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
ES2691982T3 (es) 2012-11-30 2018-11-29 Acura Pharmaceuticals, Inc. Liberación autorregulada de un principio activo farmacéutico
CN103070845B (zh) * 2013-01-14 2014-10-22 北京爱特康科贸有限责任公司 一种淀粉空心胶囊及其制备方法
CA2907950A1 (en) 2013-05-29 2014-12-04 Grunenthal Gmbh Tamper-resistant dosage form containing one or more particles
AU2014273226B2 (en) 2013-05-29 2019-06-27 Grunenthal Gmbh Tamper resistant dosage form with bimodal release profile
CN105682643B (zh) 2013-07-12 2019-12-13 格吕伦塔尔有限公司 含有乙烯-醋酸乙烯酯聚合物的防篡改剂型
JP6480936B2 (ja) 2013-11-26 2019-03-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング クライオミリングによる粉末状医薬組成物の調製
WO2015145461A1 (en) 2014-03-26 2015-10-01 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release biphasic matrix solid dosage form
WO2015173195A1 (en) 2014-05-12 2015-11-19 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
CN106456550A (zh) 2014-05-26 2017-02-22 格吕伦塔尔有限公司 避免乙醇剂量倾泻的多颗粒
GB201413832D0 (en) * 2014-08-05 2014-09-17 Tate & Lyle Ingredients Starch compositions useful for thickening aqueous liquids
CA2950148C (en) 2014-06-02 2022-07-12 Tethis, Inc. Modified biopolymers and methods of producing and using the same
CN107889459A (zh) 2015-04-24 2018-04-06 格吕伦塔尔有限公司 具有立即释放和对溶剂萃取的抗性的抗篡改剂型
WO2017040607A1 (en) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
US10842750B2 (en) 2015-09-10 2020-11-24 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
US10689566B2 (en) 2015-11-23 2020-06-23 Anavo Technologies, Llc Coated particles and methods of making and using the same
CN106337030A (zh) * 2016-08-24 2017-01-18 宁波枫叶杰科生物技术有限公司 一种治理重金属污染盐碱地的微生物制品及其制造方法
JP6216088B1 (ja) * 2017-04-21 2017-10-18 森永製菓株式会社 口腔徐放用組成物及びその製造方法
GB2567493B (en) 2017-10-13 2019-12-18 Altus Formulation Inc Starch-based release modifying excipients and pharmaceutical compositions derived therefrom
CN113121709B (zh) * 2019-12-30 2022-08-26 仙乐健康科技股份有限公司 一种变性淀粉的制备方法及应用
CN112098408B (zh) * 2020-09-14 2022-12-09 湖北亿纬动力有限公司 一种羧甲基纤维素钠溶解效果的检测方法及应用
CN117530929B (zh) * 2024-01-10 2024-03-29 东华大学 一种减肥胶囊

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2938901A (en) 1954-08-06 1960-05-31 Corn Products Co Surgical dusting powder and process therefor
US2987445A (en) 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3087860A (en) 1958-12-19 1963-04-30 Abbott Lab Method of prolonging release of drug from a precompressed solid carrier
US3034911A (en) 1959-03-25 1962-05-15 Nat Starch Chem Corp Tablet disintegrants
US3453368A (en) 1966-01-13 1969-07-01 Hoffmann La Roche Smaller high potency compressed tablets of ascorbic acid
US3490742A (en) 1966-01-14 1970-01-20 Staley Mfg Co A E Compressed tablets
US3622677A (en) 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US4072535A (en) 1970-12-28 1978-02-07 A. E. Staley Manufacturing Company Precompacted-starch binder-disintegrant-filler material for direct compression tablets and dry dosage capsules
US3904601A (en) * 1972-12-21 1975-09-09 Nat Starch Chem Corp Hydroxypropylated, inhibited high amylose retort starches
US4026986A (en) 1975-05-22 1977-05-31 The Dow Chemical Company Capsule shell
GB1576475A (en) * 1977-01-19 1980-10-08 Unilever Ltd Absorbent cross-linked starch materials
US4308251A (en) 1980-01-11 1981-12-29 Boots Pharmaceuticals, Inc. Controlled release formulations of orally-active medicaments
US4369308A (en) 1981-07-24 1983-01-18 National Starch And Chemical Corporation Low swelling starches as tablet disintegrants
US4818542A (en) 1983-11-14 1989-04-04 The University Of Kentucky Research Foundation Porous microspheres for drug delivery and methods for making same
US4551177A (en) 1984-04-23 1985-11-05 National Starch And Chemical Corporation Compressible starches as binders for tablets or capsules
US4904476A (en) 1986-03-04 1990-02-27 American Home Products Corporation Formulations providing three distinct releases
IT1200178B (it) 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
GB8812490D0 (en) 1988-05-26 1988-06-29 Agricultural & Food Res Delayed release formulations
CA2041774C (en) 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
CA2032385A1 (en) 1990-12-17 1992-06-18 Chung Wai-Chiu Enzymatically debranched starches as tablet excipients
DE69302580T2 (de) 1992-07-24 1996-09-26 Labopharm Inc Vernetztes polyhydroxyl-material zur enzymatisch gesteuerten arzneistofffreisetzung
US5616343A (en) 1993-03-25 1997-04-01 Labopharm, Inc. Cross-linked amylose as a binder/disintegrant in tablets
US5830884A (en) 1995-01-18 1998-11-03 National Starch And Chemical Investment Holding Corporation Pharmaceutical products containing thermally-inhibited starches
JP3949746B2 (ja) * 1996-02-28 2007-07-25 日澱化學株式会社 硝子繊維集束剤用化工澱粉
US5879707A (en) 1996-10-30 1999-03-09 Universite De Montreal Substituted amylose as a matrix for sustained drug release
US5807575A (en) 1997-02-14 1998-09-15 Rougier Inc. Manufacture of cross-linked amylose useful as a excipient for control release of active compounds
US6284273B1 (en) * 1998-02-24 2001-09-04 Vincent Lenaerts Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds
US6607748B1 (en) * 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture

Also Published As

Publication number Publication date
KR100840393B1 (ko) 2008-06-23
CN100352509C (zh) 2007-12-05
NO20026254L (no) 2003-02-27
HK1059574A1 (en) 2004-07-09
ATE328585T1 (de) 2006-06-15
NO20026254D0 (no) 2002-12-27
JP5025066B2 (ja) 2012-09-12
TWI289460B (en) 2007-11-11
BRPI0112140B8 (pt) 2021-05-25
IL153654A (en) 2008-12-29
RU2274443C2 (ru) 2006-04-20
WO2002002084A1 (en) 2002-01-10
ES2272499T3 (es) 2007-05-01
WO2002002084A8 (en) 2002-04-04
PT1305009E (pt) 2006-10-31
AR029549A1 (es) 2003-07-02
PL365634A1 (en) 2005-01-10
EP1305009A1 (en) 2003-05-02
US6607748B1 (en) 2003-08-19
BR0112140A (pt) 2003-10-07
CN1449279A (zh) 2003-10-15
US20040013726A1 (en) 2004-01-22
CZ20024269A3 (cs) 2003-06-18
EP1305009B1 (en) 2006-06-07
KR20030031504A (ko) 2003-04-21
AU7148101A (en) 2002-01-14
CZ300152B6 (cs) 2009-02-25
PL202177B1 (pl) 2009-06-30
NZ523644A (en) 2005-10-28
EP1305009A4 (en) 2004-11-17
CA2414349C (en) 2008-09-16
HUP0301302A2 (en) 2003-08-28
DK1305009T3 (da) 2006-12-27
SI1305009T1 (sl) 2007-08-31
MY128308A (en) 2007-01-31
MXPA03000035A (es) 2005-09-21
AU2001271481B2 (en) 2005-05-26
IL153654A0 (en) 2003-07-06
DE60120413D1 (de) 2006-07-20
JP2004501957A (ja) 2004-01-22
CA2414349A1 (en) 2002-01-10
DE60120413T2 (de) 2007-06-14

Similar Documents

Publication Publication Date Title
BR0112140B1 (pt) comprimido de liberaÇço controlada, processo para a fabricaÇço, em um meio aquoso, de um excipiente de liberaÇço controlada e amido reticulado de elevado teor de amilose.
BR0005872B1 (pt) sistema de agente de impermeabilização, seu emprego, processo para a impermeabilização de substratos, bem como substratos assim obtidos.
DE60003281D1 (de) Thermisches Übertragungsverfahren.
BR0112124B1 (pt) pà de celulose, processo para produzir um pà de celulose, excipiente, e, produto moldado.
HUP0303715A3 (en) Aqueous adhesive system, method for the production and use thereof
PT1056759E (pt) Derivados do 2-(purin-9-il)-tetrahidrofurano-3,4-diolc
BR0114148B1 (pt) método e sistema para gravação em relevo por extrusão.
BR0210005B1 (pt) Polímero, processo para o preparo do mesmo e estrutura absorvente.
BR0014569B1 (pt) artigo adesivo e mÉtodo para formar um artigo adesivo.
DE60027521D1 (de) Energieabsorbierender, biegender Scherstreifen
BR0104896B1 (pt) processo para a sìntese de uréia.
DE60030693D1 (de) Kompressive innenhochdruckformung
BR0003039B1 (pt) folha plÁstica composta e processo para fabricaÇço da mesma.
DK1098848T3 (da) Hidtil ukendt dispergerbart aluminiumhydrat, fremgangsmåde til dets fremstilling af dets anvendelse til fremstilling af katalysatorer
BR0100120B1 (pt) artigo absorvente decomponÍvel em Água, e, processo para produzir o mesmo.
BR0110043B1 (pt) agente geleificante reversÍvel, uso do mesmo, gel, produto alimentÍcio, e, processos para a formaÇço de um gel e para romper um gel.
BR9917475B1 (pt) processo para a manufatura de compostos, e, modificação do processo.
MXPA01008148A (es) Derivados de epotilona, metodo para su produccion y su uso farmaceutico.
BR0109988B1 (pt) elemento eletroquìmico, e, processo para preparar o mesmo.
AU2002220568A1 (en) Multicomponent system which can be hardened by means of heat and actinic radiation, and use of the same
ID26611A (id) Turunan-turunan pirol tersubstitusi heteroaril, pembuatannya dan kegunaan-kegunaan terapetiknya
BR0016149B1 (pt) 5-(1-piperazinil)benzofuran-2-carboxiamida e processo para sua preparação por aminação catalisada por metal de transição.
NO20024439L (no) Polymert, akrylamidfritt middel for tilbakeholdelse av vann
BR0304151B1 (pt) composição de gesso modificado por polìmero, processo para formar um gesso modificado por polìmero, e, gesso modificado por polìmero.
PT1290307E (pt) Elemento de construcao, utilizacao de um elemento de construcao e processo paraa producao de um elemento de construcao

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 30/04/2013, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/06/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B15V Prolongation of time limit allowed
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 22A ANUIDADE.

B21H Decision of lapse of a patent or of a certificate of addition of invention cancelled [chapter 21.8 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 21.6 NA RPI NO 2728 DE 18/04/2023 POR TER SIDO INDEVIDA.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 26/06/2021